Form 4: Sanjay Srivastava receives 205,858 RSUs from XBP Global Holdings
Rhea-AI Filing Summary
Insider grant recorded: Sanjay Srivastava, identified as a director of XBP Global Holdings, Inc., was granted 205,858 restricted stock units (RSUs) on 09/09/2025 at no cash price. The RSUs were issued under the companys 2024 Stock Incentive Plan, as amended, and are scheduled to vest in full on August 1, 2026. The Form 4 was signed on behalf of Mr. Srivastava by an attorney-in-fact, Ross Dawson, on 09/11/2025. The filing indicates direct beneficial ownership following the transaction of 205,858 shares and lists the reporting persons address as C/O XBP Global Holdings, Inc., Irving, TX.
Positive
- 205,858 RSUs were granted to a director, showing direct alignment of the directors compensation with shareholder value
- Full vesting date provided (August 1, 2026), giving clear timing for when shares become owned
Negative
- None.
Insights
TL;DR: A director received a sizeable RSU grant that vests in under a year, aligning executive incentives with shareholder outcomes.
The grant of 205,858 RSUs to a director under the 2024 Stock Incentive Plan is a typical equity-compensation action to align management and board incentives with company performance. The zero-dollar price and explicit vesting date of August 1, 2026 indicate these are restricted units rather than open-market purchases. From a governance perspective, disclosure via Form 4 is routine and appropriate. Materiality depends on company scale; the filing alone does not disclose total outstanding shares or percentage ownership, so the investor impact cannot be fully assessed from this document alone.
TL;DR: Filing properly reports equity grant and meets Section 16 reporting requirements; signed by attorney-in-fact.
The Form 4 lists the transaction date, grant amount, grant vehicle (RSUs), vesting schedule, and that the grant was issued under the companys 2024 plan. The form shows direct beneficial ownership after the transaction and is executed by an authorized agent, satisfying signature requirements. No derivative securities or dispositions are reported. The filing does not provide information on percentage ownership, dilutive impact, or other holdings that would be needed to evaluate regulatory thresholds or control implications.